TP53 and myeloproliferative disorder: To investigate the potential effects of CBL0137 on TP53 activation we chose to use a luciferase TP53 reporter system in a JAK2V617F expressing cell line model we have previously successfully used to identify drug targets in MPN [11, 17, 23].